For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Atossa Therapeutics Inc (NASDAQ: ATOS) was $0.62 for the day, down -5.63% from the previous closing price of $0.66. In other words, the price has decreased by -$5.63 from its previous closing price. On the day, 1.66 million shares were traded. ATOS stock price reached its highest trading level at $0.6548 during the session, while it also had its lowest trading level at $0.6152.
Ratios:
Our analysis of ATOS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.77 and its Current Ratio is at 6.77. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Maxim Group on January 26, 2018, initiated with a Buy rating and assigned the stock a target price of $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 21 ’25 when QUAY STEVEN C bought 11,239 shares for $0.88 per share. The transaction valued at 9,887 led to the insider holds 13,898 shares of the business.
Remmel H. Lawrence bought 10,000 shares of ATOS for $7,000 on Mar 26 ’25. The Director now owns 10,257 shares after completing the transaction at $0.70 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATOS now has a Market Capitalization of 80280040 and an Enterprise Value of 28435040.
Stock Price History:
The Beta on a monthly basis for ATOS is 1.08, which has changed by -0.3125 over the last 52 weeks, in comparison to a change of 0.17673707 over the same period for the S&P500. Over the past 52 weeks, ATOS has reached a high of $1.29, while it has fallen to a 52-week low of $0.55. The 50-Day Moving Average of the stock is -22.31%, while the 200-Day Moving Average is calculated to be -23.92%.
Shares Statistics:
ATOS traded an average of 1.05M shares per day over the past three months and 1120720 shares per day over the past ten days. A total of 129.17M shares are outstanding, with a floating share count of 129.10M. Insiders hold about 0.06% of the company’s shares, while institutions hold 19.43% stake in the company. Shares short for ATOS as of 1765756800 were 2284050 with a Short Ratio of 2.18, compared to 1763078400 on 1379122. Therefore, it implies a Short% of Shares Outstanding of 2284050 and a Short% of Float of 2.0.
Earnings Estimates
. The current assessment of Atossa Therapeutics Inc (ATOS) involves the perspectives of 3.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.06 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.24 and -$0.26 for the fiscal current year, implying an average EPS of -$0.25. EPS for the following year is -$0.29, with 3.0 analysts recommending between -$0.26 and -$0.32.
